Kiniksa Pharmaceuticals International, plc KNSA Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's operating lease ROU assets?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported operating lease ROU assets of $9.33M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's operating lease ROU assets changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's operating lease ROU assets decreased by 10.7% year-over-year, from $10.45M to $9.33M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's operating lease ROU assets?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's operating lease ROU assets has grown at a 8.4% compound annual growth rate (CAGR), from $6.57M to $9.81M.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.